Clinical observations on safety of fixed dose rate gemcitabine chemotherapy by intravenous infusion.

Abstract

The toxicity of iv-FDR gemcitabine combination chemotherapy was well tolerated, so that iv-FDR gemcitabine deserves to be further studied as a treatment option.